cas 1268491-68-4|| where to buy Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, 3'-hydroxy-3-oxo-6'-[[(trifluoromethyl)sulfonyl]oxy]-

Nom du produit:Spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-6-carboxylic acid, 3'-hydroxy-3-oxo-6'-[[(trifluoromethyl)sulfonyl]oxy]-

IUPAC Name:3'-hydroxy-3-oxo-6'-(trifluoromethanesulfonyloxy)-3H-spiro[2-benzofuran-1,9'-xanthene]-6-carboxylic acid

: CAS：1268491-68-4; Formule moléculaire：C22H11F3O9S; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)
CM476425-100mg	in stock	ňȀŭ
CM476425-250mg	in stock	ƻŔȀ
CM476425-1g	1-2 Weeks	ŔȀǕȀ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1268491-68-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1268491-68-4; Formule moléculaire:C22H11F3O9S; Point de fusion:-; Code SMILES:OC(=O)C1=CC=C2C(=O)OC3(C2=C1)C1=CC=C(O)C=C1OC1=CC(OS(=O)(=O)C(F)(F)F)=CC=C31; Densité:

: Numéro de catalogue:CM476425; Poids moléculaire:508.38; Point d'ébullition:; N° Mdl:MFCD29472318; Stockage:

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.